RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R10332 | Molibresib (Synonyms: GSK 525762A; I-BET 762) | Molibresib (GSK 525762A; I-BET 762) is a BET bromodomain inhibitor with IC50 of |
| R10349 | AMI-1 | AMI-1 is a potent and specific Histone Methyltransferase (HMT) inhibitor with IC |
| R10369 | GSK126 | GSK126 is a potent, highly selective EZH2 methyltransferase inhibitor with IC50 |
| R10372 | Baricitinib (INCB28050, LY3009104) | Baricitinib (LY3009104, INCB028050) is a selective JAK1 and JAK2 inhibitor with |
| R10374 | Ruxolitinib phosphate;INCB018424 phosphate | Ruxolitinib (INCB018424) is the first potent, selective, JAK1/2 inhibitor to ent |
| R10409 | (+)-JQ1 | (+)-JQ1 is a BET bromodomain inhibitor, with IC50 of 77 nM/33 nM for BRD4(1/2) i |
| R10422 | BRD73954 | BRD73954 is a potent and selective HDAC inhibitor with IC50 of 36 nM and 120 nM |
| R10424 | JNJ26481585; Quisinostat | Quisinostat is an orally available, potent, hydroxamate, pan-HDACi with broad ac |
| R10494 | Tasocitinib; CP-690550 | Tofacitinib (CP-690550,Tasocitinib) is a novel inhibitor of JAK3 with IC50 of 1 |
| R10516 | Decitabine; NSC127716 | Decitabine is a potent inhibitor of DNA methylation, used to treat myelodysplast |
| R10536 | Tofacitinib citrate (Tasocitinib citrate; CP-690550 citrate) | Tofacitinib (CP-690550) Citrate is a novel inhibitor of JAK3 with IC50 of 1 nM i |
| R10568 | Fedratinib; TG101348 | Fedratinib (SAR302503, TG101348) is a selective inhibitor of JAK2 with IC50 of 3 |
| R10572 | Belinostat;PXD101 | Belinostat (PXD101) is a novel HDAC inhibitor with IC50 of 27 nM in a cell-free |
| R10617 | Pracinostat (SB939) | Pracinostat (SB939) is a potent pan-HDAC inhibitor with IC50 of 40-140 nM with e |
| R10621 | JW55 | JW 55 is an inhibitor of the PARP domain of tankyrase 1 and 2 (TNKS1/2). |
| R10669 | TMP269 | TMP269 is a potent, selective class IIa HDAC inhibitor with IC50 of 157 nM, 97 n |
| R10671 | NexturastatA | Nexturastat A is a potent and selective HDAC6 inhibitor with IC50 of 5 nM, >1 |
| R10673 | NSC 42834；JAK2 Inhibitor V; Z3 | Z3 is a novel specific inhibitor of Jak2 tyrosine kinase. |
| R10681 | NSC693627; AC1O75RE; JIB04; FD5031; NSC-693627 | JIB-04 is a pan-selective Jumonji histone demethylase inhibitor with IC50 of 230 |
| R10697 | HDAC-IN-7 (Chidamide impurity) | Chidamide(CS055; HBI-8000) is a class I HDAC inhibitor with IC50s of 95/160/67/7 |
| R10702 | RG108;N-Phthalyl-L-tryptophan | RG108 is an inhibitor of DNA methyltransferase with IC50 of 115 nM in a cell-fre |
| R10709 | JANEX-1 (Synonyms: WHI-P131; Jak3 inhibitor I) | Janex-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific i |
| R10710 | WHI-P180 | WHI-P180 (Janex 3) is a multi-kinase inhibitor; inhibits RET, KDR and EGFR with |
| R10732 | MC1568 | MC1568 is a selective HDAC inhibitor for maize HD1-A with IC50 of 100 nM in a ce |
| R10759 | CAY10683;Santacruzamate A | Santacruzamate A (CAY10683) is a potent and selective HDAC inhibitor with IC50 o |
